Emmaus Life Sciences

Entity > Corporation > US > New York City New York > Emmaus Life Sciences

About Emmaus Life Sciences

Emmaus Life Sciences, Inc. is a biopharmaceutical company. Emmaus Life Sciences, Inc. focuses on rare and orphan diseases, such as sickle cell disease.

Emmaus Life Sciences, Inc. Offers Products For The Treatment Of Sickle Cell Disease: Emmaus Life Sciences, Inc. is in clinical development of a patented experimental treatment approach of an orally administered pharmaceutical grade L-glutamine to treat some of the symptoms of sickle cell disease (SCD). Emmaus Life Sciences, Inc.'s lead commercial product is Endari®. The product candidate showed positive clinical results in the completed Phase 3 clinical trial for sickle cell anaemia and sickle SS0 thalassemia.

Emmaus Life Sciences, Inc.’s Founding and Headquarters: Emmaus Life Sciences, Inc. was founded in 2000 by Yutaka Niihara, M.D., M.P.H. Emmaus Life Sciences, Inc. is currently headquartered in Torrance, California, USA.


More information about Emmaus Life Sciences

Company Attribute Value
Name Emmaus Life Sciences
Url emmausmedical
Google google

Emmaus Life Sciences


New York City, US
24 Jan 2024

New York City, US
24 Jan 2024

Emmaus Life Sciences

Page: 1 Desktop | Laptop Devices

Emmaus Life Sciences
Emmaus Life Sciences, Inc
https://www.biospace.com › employer › emmaus-life-s...
Articles about Emmaus Life Sciences (Formerly Known As ...
https://www.prnewswire.com › news-releases › emmau...
Emmaus Life Sciences Reports Management Changes
https://www.sicklecelldisease.org › emmaus-life-science
Emmaus Life Science
https://www.prnewswire.com › news-releases › emmau...
Emmaus Life Sciences Reports Q3 2023 Financial Results
https://finance.yahoo.com › quote › EMMA
Emmaus Life Sciences, Inc. (EMMA) Stock Price, News, ...
https://pitchbook.com › profiles › company
Emmaus Life Sciences Company Profile
Related Searches
Related Searches
Emmaus life sciences stock
emmaus medical logo
Emmaus life sciences salary
Knowledge Panel
Knowledge Panel

EMI Holding, Inc. (Pharmaceutical company)


Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. We are initially focusing our product development efforts in Sickle Cell Disease, a genetic disorder.

  • Headquarters : Torrance, CA
  • Stock price : EMMA (OTCMKTS) $0.10 0.00 (-4.75%)Jan 23, 4:00 PM EST - Disclaimer
  • Subsidiaries : Emmaus Medical, MYnd Analytics California, MORE
  • Founded : 1987

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194157